We are live on ! Find out more
FA

Fagan Associates Portfolio holdings

AUM $813M
1-Year Est. Return 37.92%
This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
+37.92%
3 Year Est. Return
+110.01%
5 Year Est. Return
+134.08%
10 Year Est. Return
+676.44%
AUM
$246M
AUM Growth
+$12.4M
Cap. Flow
+$4M
Cap. Flow %
1.62%
Top 10 Hldgs %
38.42%
Holding
118
New
7
Increased
68
Reduced
27
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 18.3%
2 Financials 16.78%
3 Communication Services 11.51%
4 Consumer Discretionary 11.12%
5 Industrials 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLE icon
101
State Street Energy Select Sector SPDR ETF
XLE
$39.9B
$274K 0.11%
8,592
+494
+6% +$15.8K
CMCSA icon
102
Comcast
CMCSA
$92.9B
$263K 0.11%
6,210
+524
+9% +$22.1K
PFE icon
103
Pfizer
PFE
$153B
$262K 0.11%
6,383
+933
+17% +$37K
CONE
104
DELISTED
CyrusOne Inc Common Stock
CONE
$260K 0.11%
+4,505
New +$264K
OHI icon
105
Omega Healthcare
OHI
$13.9B
$244K 0.1%
+6,640
New +$242K
EW icon
106
Edwards Lifesciences
EW
$53.4B
$243K 0.1%
3,945
SCHX icon
107
Schwab US Large- Cap ETF
SCHX
$75B
$224K 0.09%
19,128
-300
-2% -$3.45K
PEP icon
108
PepsiCo
PEP
$192B
$221K 0.09%
1,684
+1
+0.1% +$128
SPHY icon
109
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$12.1B
$211K 0.09%
8,075
ITOT icon
110
iShares Core S&P Total US Stock Market ETF
ITOT
$98.5B
$210K 0.09%
+3,155
New +$207K
AXP icon
111
American Express
AXP
$232B
$205K 0.08%
+1,660
New +$195K
ED icon
112
Consolidated Edison
ED
$40.1B
$201K 0.08%
+2,288
New +$197K
BMY icon
113
Bristol-Myers Squibb
BMY
$132B
-4,310
Closed -$206K
FLR icon
114
Fluor
FLR
$7B
-5,705
Closed -$210K
MOS icon
115
The Mosaic Company
MOS
$6.92B
-29,370
Closed -$802K
REGN icon
116
Regeneron Pharmaceuticals
REGN
$83B
-550
Closed -$2.26M
TTWO icon
117
Take-Two Interactive
TTWO
$45.2B
-20,685
Closed -$1.95M
NEWR
118
DELISTED
New Relic, Inc.
NEWR
-5,350
Closed -$528K

Similar funds

Fagan Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Fagan Associates held 118 positions worth $246M, up 5.3% from $234M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Fagan Associates's Q2 2019 filing shows 7 new, 68 increased, 27 reduced and 6 closed positions. Its largest new stake was Advanced Micro Devices: 63,470 shares worth $1.93M. The largest sale was Regeneron Pharmaceuticals, an estimated $2.26M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.

  • Fagan Associates's largest Q2 2019 buy was Advanced Micro Devices: 63,470 shares worth $1.93M.
  • Fagan Associates added most to Walt Disney in Q2 2019, an estimated $475K increase.
  • Fagan Associates's biggest Q2 2019 reduction was Intel, cutting an estimated $64.4K.
  • Fagan Associates fully exited Regeneron Pharmaceuticals in Q2 2019, selling an estimated $2.26M.
  • Fagan Associates's ten largest holdings make up 38% of its $246M portfolio in Q2 2019.
  • Fagan Associates opened 7 new positions and closed 6 in Q2 2019.
  • Fagan Associates's portfolio value rose 5.3% quarter-over-quarter to $246M.

Based on Fagan Associates's 13F filing for Q2 2019, filed 12 Jul 2019.